Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 6;27(2):254-269.e9.
doi: 10.1016/j.stem.2020.06.007. Epub 2020 Jul 7.

Generation of Functional Liver Sinusoidal Endothelial Cells from Human Pluripotent Stem-Cell-Derived Venous Angioblasts

Affiliations
Free article

Generation of Functional Liver Sinusoidal Endothelial Cells from Human Pluripotent Stem-Cell-Derived Venous Angioblasts

Blair K Gage et al. Cell Stem Cell. .
Free article

Abstract

Liver sinusoidal endothelial cells (LSECs) form a highly specialized microvasculature that plays a critical role in liver function and disease. To better understand this role, we developed a strategy to generate LSECs from human pluripotent stem cells (hPSCs) by first optimizing the specification of arterial and venous angioblasts and derivative endothelial populations. Induction of a LSEC-like fate by hypoxia, cyclic AMP (cAMP) agonism, and transforming growth factor β (TGF-β) inhibition revealed that venous endothelial cells responded more rapidly and robustly than the arterial cells to upregulate LSEC markers and functions in vitro. Upon intrahepatic transplantation in neonates, venous angioblasts engrafted the liver and generated mature, fenestrated LSECs with scavenger functions and molecular profiles of primary human LSECs. When transplanted into the liver of adult mice, angioblasts efficiently gave rise to mature LSECs with robust factor VIII (FVIII) production. Humanization of the murine liver with hPSC-derived LSECs provides a tractable system for studying the biology of this key liver cell type.

Keywords: FVIII; LSEC; VEGF-A; artery; fenestration; hPSC; humanized hepatic vasculature; hypoxia; liver sinusoidal endothelial cell; sinusoid; vein.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests G.M.K. is a founding investigator and a paid consultant for BlueRock Therapeutics LP, a paid consultant for VistaGen Therapeutics, and a member of the board of Anagenesis Biotechnologies. B.K.G. and G.M.K. declare a patent titled “Methods of Producing Venous Angioblasts and Sinusoidal Endothelial Cell – Like Cells and Compositions Thereof” (no. PCT/IB2019/057882) filed September 18, 2019 related to this work.

Publication types

Substances

Grants and funding

LinkOut - more resources